ACCESSWIRE
13 May 2022, 00:13 GMT+10
- Live video webcast with moderated fireside chat with members of the Cyclo Therapeutics leadership team and Global Principal Investigator for the Phase 3 study, Professor Caroline Hastings, MD, on Monday, May 16th at 2:00 PM ET -
FRENCHTOWN, NJ / ACCESSWIRE / May 12, 2022 / JTC Team ('JTC'), a fully integrated corporate communications and investor relations firm, today announced it will host the Virtual Investor Niemann-Pick Disease Type C (NPC) Spotlight Event Featuring Cyclo Therapeutics on Monday, May 16, 2022 at 2:00 PM ET. Access the event here.
Cyclo Therapeutics, Inc. (Nasdaq: CYTH) is a late clinical-stage biotechnology company dedicated to developing life-changing medicines through science and innovation for patients and families suffering from disease. As part of the event, Cyclo Therapeutics will discuss NPC, a rare, progressive and fatal genetic disorder characterized by abnormal accumulation of cholesterol in cells, and its ongoing development program of Trappsol® Cyclo™ for the treatment of NPC. Trappsol® Cyclo™ is the Company's proprietary formulation of hydroxypropyl beta cyclodextrin, used intravenously (IV), which in multiple clinical studies has shown encouraging results to normalize the transportation of cholesterol in cells.
For the discussion, Lise Lund Kjems, MD, PhD, Chief Medical Officer and Lori McKenna Gorski, Global Head of Patient Advocacy of Cyclo Therapeutics will be joined by Professor Caroline Hastings, MD, Chair of the Phase 3 Trappsol® Cyclo™ Program Steering Committee and the Global Principal Investigator for the Company's ongoing TransportNPC™ study evaluating Trappsol® Cyclo™ for the treatment of NPC.
Dr. Hastings currently serves as the Pediatric hematologist oncologist, Director of Neuro-oncology, and Professor of Pediatrics at UCSF Benioff Children's Hospital Oakland and is an advisor to U.S. and Australian NPC Advocacy organizations and to physicians globally on NPC. She has been practicing in the field of Pediatric Hematology Oncology since 1992 and has served as the director of the fellowship program at the Children's Hospital & Research Center Oakland since 1996. She has devoted herself to her patients and to fostering education in this specialty. Her academic interests include tumors of the brain and spinal cord, relapsed acute lymphoblastic leukemia, and lysosomal storage diseases including Niemann Pick Type C disease.
A live video webcast of the Virtual Investor Niemann-Pick Disease Type C Spotlight Event Featuring Cyclo Therapeutics will be available on virtualinvestorco.com. A webcast replay will be made available shortly after the conclusion of the live event and will be accessible for 90 days.
About JTC Team
JTC is a fully integrated corporate communications firm that is dedicated to helping you tell your story to the right audiences in order to build awareness. JTC has developed a reputation of excellence for executing on robust communication strategies that deliver results. The Company partners with both public and private companies across the Life Sciences and Technology industries to help raise awareness and build stakeholder value. For more information, please visit www.jtcir.com or connect with the company on Twitter and LinkedIn.
Contact:
Jenene Thomas
JTC Team, LLC
T: +1 (833) 475-8247
jtc@jtcir.com
SOURCE: JTC Team, LLC
Get a daily dose of Nashville Herald news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Nashville Herald.
More InformationTOKYO, Japan: U.S. President Joe Biden said this week that he supports calls for Japan to become a permanent member ...
LONDON, England: The UK's Telegraph newspaper has reported that Foreign Secretary Liz Truss has proposed that Britain send modern weaponry ...
SHANGHAI, China: The central Shanghai district of Jingan, a key commercial area in China's financial hub, has announced that it ...
KYIV, Ukraine: Andrzej Duda, President of Poland, told lawmakers in Kyiv this week that Ukraine has the right to decide ...
SAN ANTONIO, Texas (ANI/Big News Network): The death toll in the mass shooting incident at a school in Texas now ...
LONDON, England: Citing a U.S. official, the Financial Times reported this week that during the Quad summit in Tokyo, the ...
NEW YORK CITY, New York: The market for global online tutoring services is expected to grow from $21 million in ...
SYDNEY, NSW, Australia - Shares across Asia fell on Thursday, with the exception of the Chinese mainland market where modest ...
SANTIAGO, Chile: Easter Island, one of Chile's most important tourist attractions, will reopen to visitors on August 1, the government ...
NEW DEHLI, India: In a move expected to end the country's exports of the raw materials needed to manufacture steel, ...
NEW YORK, New York - The release of the minutes of the Federal Reserve's monetary meeting earlier this month surprisingly ...
WASHINGTON D.C.: A leading U.S. official has said that even if Taiwan is excluded from President Joe Biden's Asian economic ...